Company: IMNN
Filing Date: 2025-05-30
Form Type: PRE 14A
Source: 0001641172-25-013068
Chunk: 24

Company: Imunon, Inc.
Filing Date: 2025-05-30
Form: PRE 14A
Chunk 24
---
:----|:-----|--:|
| Total Number of Directors: 6            |     |        |   |     |      |   |
| Part I: Gender                          
 Identity                                |     | Female |   |     | Male |   |
| Directors                               |     |        | 2 |     |      | 4 |
| Part II: Demographic Background         |     |        |   |     |      |   |
| African American or Black               |     |        | 0 |     |      | 0 |
| Alaskan Native or Native American       |     |        | 0 |     |      | 0 |
| Asian                                   |     |        | 0 |     |      | 0 |
| Hispanic or Latinx                      |     |        | 0 |     |      | 0 |
| Native Hawaiian or Pacific Islander     |     |        | 0 |     |      | 0 |
| White                                   |     |        | 2 |     |      | 4 |
| Two or More Races or Ethnicities        |     |        | 0 |     |      | 0 |
| LGBTQ+                                  |     |        | 0 |     |      |   |
| Did Not Disclose Demographic Background |     |        | 0 |     |      |   |

Director Independence

In accordance with the rules of the SEC and Nasdaq, the Company requires that at least a majority of the directors serving at any time on the Board of Directors be independent, that at least three directors satisfy the financial literacy requirements for service on the Audit Committee and that at least one member of the Audit Committee qualify as an “audit committee financial expert” under those rules.

Mr. Dentzer acts as the chairman of our Audit Committee. The Board has determined that Mr. James E. Dentzer is qualified to serve as the “audit committee financial expert” as defined by Item 407(d)(5) of Regulation S-K and that Mr. Fritz and Ms. Pellizzari meet the financial literacy requirements under applicable SEC and Nasdaq rules. The Board of Directors determined that of the six currently serving directors, four directors (Dr. Braun, Messrs. Dentzer and Fritz and Ms. Pellizzari) are independent under applicable SEC and Nasdaq rules.

| 20 |

Nominating and Governance Committee Process

In selecting candidates for our Board of Directors, the Nominating and Governance Committee begins by determining whether the incumbent directors whose terms expire